Raia Drogasil (RADLY) Stock Price, News & Analysis

Company Overview

Raia Drogasil S.A. (OTCMKTS: RADLY) is a leading Brazilian retail pharmacy chain focused on the distribution and sale of pharmaceutical products, over-the-counter medicines, cosmetics, personal care items and wellness goods. Headquartered in São Paulo, the company serves a broad consumer base through a network of more than 2,400 stores located across all regions of Brazil. In addition to its brick-and-mortar operations, Raia Drogasil offers digital services, including online prescription fulfillment and home delivery, enabling customers to access its product portfolio through multiple channels.

The company’s core business activities encompass retail pharmacy operations, supply-chain logistics and distribution, private-label manufacturing and commercial partnerships with pharmaceutical laboratories. Raia Drogasil integrates store operations with advanced inventory management systems and regional distribution centers to maintain high product availability, support rapid replenishment and ensure regulatory compliance with Brazilian health authorities. Its private-label brands and loyalty programs are designed to enhance customer retention and differentiate its product offering in a competitive marketplace.

Raia Drogasil traces its origins to the merger of two historic pharmacy chains, Farmácias Raia and Drogasil, in 2011. The combined entity has since grown through strategic acquisitions and organic expansion, solidifying its position as Brazil’s largest drugstore operator. The company is governed by an executive board with extensive experience in retail, healthcare and supply-chain management. As a publicly traded company on both the B3 exchange (RADL3) and the OTC market (RADLY), Raia Drogasil adheres to rigorous corporate governance standards and regularly publishes operational and sustainability reports to inform investors and stakeholders.

Key Stats

• Today's Range: $2.55 to $2.62
• 50-Day Range: $2.22 to $3.10
• 52-Week Range: $2.21 to $14.00
• Volume: 2,009 shs
• Average Volume: 4,767 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RADLY Stock Analysis - Frequently Asked Questions

How have RADLY shares performed this year?

Raia Drogasil's stock was trading at $3.25 on January 1st, 2025. Since then, RADLY stock has decreased by 21.5% and is now trading at $2.55.

When did Raia Drogasil's stock split?

Raia Drogasil's stock split on Monday, May 22nd 2023.The 26-25 split was announced on Monday, May 22nd 2023. The newly created shares were payable to shareholders after the market closes on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the split would have 104 shares after the split.

How do I buy shares of Raia Drogasil?

Shares of RADLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Record date for 6/9 Dividend: 12/12/2024
• Ex-Dividend for 6/9 Dividend: 12/12/2024
• Dividend Payable: 6/09/2025
• Today: 7/18/2025
• Next Earnings (Estimated): 8/05/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical Retailers
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RADLY
• CIK: N/A
• Web: www.rd.com.br
• Phone: 551137695678
• Fax: N/A
• Employees: 57,708
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A